Cencora, Inc.
COR Healthcare Medical Distribution
Cencora, Inc.’s revenue for fiscal 2026 (year ended September 2026) was $337.4 billion, up 5.00% from fiscal 2025.
- Revenue
- +5.52%
- EPS
- +258.4%
- Free cash flow
- −7.81%
- Total debt
- +47.1%
Quarter to September 2026, against a year earlier
Follow COR
Alert me
Cencora, Inc. (COR) Current ratio
Cencora, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 0.9×. Over the past ten years it has ranged from 0.9× (fiscal 2023) to 1.0× (fiscal 2020); the current reading is higher than 67% of that period. That is below the Medical Distribution industry median of 1.0× and below the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2026 | 0.9× | 3.71% |
| FY2025 | 0.9× | 2.76% |
| FY2024 | 0.9× | 0.31% |
| FY2023 | 0.9× | (3.74%) |
| FY2022 | 0.9× | (2.94%) |
| FY2021 | 0.9× | (3.91%) |
| FY2020 | 1.0× | 2.67% |
| FY2019 | 1.0× | 2.36% |
| FY2018 | 0.9× | 2.53% |
| FY2017 | 0.9× | 0.25% |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 0.9× | 0.24% |
| Jun 2026 | 0.9× | (1.26%) |
| Mar 2026 | 0.9× | 3.37% |
| Dec 2025 | 0.9× | 1.36% |
| 43 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| FOCL FocalTherics compare | 1.6× |
| AHG Akso Health Group Sponsored ADR compare | 1.5× |
| HSIC Henry Schein, Inc. compare | 1.3× |
| YI 111, Inc. Sponsored ADR compare | 1.1× |
| COSM Cosmos Health Inc. compare | 1.1× |
| COR Cencora, Inc. | 0.9× |
| MCK McKesson Corporation compare | 0.9× |
| CAH Cardinal Health, Inc. compare | 0.9× |
| ACH Accendra Health, Inc. compare | 0.4× |
| Medical Distribution industry median | 1.0× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on COR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement